Last reviewed · How we verify

NCT04213235: EDuCA

Educational Materials Development for Physical Activity in CAncer

Status unknown NA Last updated 30 December 2019
What this trial tests

NA trial testing Physical activity in Mixed Cancer in 25 participants. Status unknown.

Timeline
1 January 2020
Primary endpoint
1 November 2020
1 November 2020

Quick facts

Lead sponsorUniversita di Verona
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment25
Start date1 January 2020
Primary completion1 November 2020
Estimated completion1 November 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Universita di Verona — full company profile →

Who can join

18 and older, any sex, with Mixed Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In cancer setting, physical exercise has emerged as an important factor to control cancer-related symptoms and improve patients' quality of life. In addition, the correlation between physical activity and survival is recently consolidating. Nevertheless, several previous studies have shown that the majority of cancer patients are insufficiently active. Written information, for example a guidebook, may be a good oppurtunity, to improve lifestyle. Developing and testing an exercise guidebook, based on Theory of Planned Behavior and specifically designed for cancer patients, may be an effective tool to deliver information and increase physical activity level in this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Physical activity

Trials testing the same drug.

Other Universita di Verona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04213235.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing